Division of Interventional Biological Psychiatry, Department of Psychiatry and Psychotherapy, University Hospital Freiburg; Division of Experimental Psychiatric Stimulation Techniques of the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN), Psychosomatik und Nervenheilkunde e. V. Berlin; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim Medical Faculty; Center of Neurology, The Hertie Institute for Clinical Brain Research, Clinic of Neurology at the University Hospital Tübingen; German Center of Neurodegenerative Diseases (DZNE), Tübingen; Clinic for Stereotaxy and Functional Neurosurgery, University Hospital Cologne; University Department of Stereotactic Neurosurgery, Universitätsklinikum Magdeburg; Medical Center-University of Freiburg, Department of Stereotactic and Functional Neurosurgery, Department of Neurosurgery.
Dtsch Arztebl Int. 2021 Jan 22;118(3):31-36. doi: 10.3238/arztebl.m2021.0017.
Drugs, psychotherapy, and other treatment modalities are effective for many patients with mental illness. Nonetheless, many patients do not achieve a total remission with the currently available interventions, and the recurrence rates are high. As part of the ongoing search for further treatment options for refractory disorders, there is renewed interest in focal neuromodulatory techniques, including invasive ones, and deep brain stimulation (DBS) in particular.
In this review article, a group consisting of neurosurgeons, psychiatrists, and one practicing ethicist/neurologist summarizes the main aspects of the use of DBS to treat mental illness and offers recommendations on its indications and practical implementation.
The efficacy of DBS against mental illness has not been confirmed in the randomized, controlled trials (RCTs) that have been published to date. This may be because the follow-up times were too short. In contrast to the negative RCTs, case series have indeed shown a positive effect of DBS on severe depression, but this effect can only be seen several months after the operation.
DBS may be a therapeutic option for selected patients with otherwise intractable mental illness. Patients should only be treated in the setting of clinical trials. RCTs with longer follow-up times must be conducted in order to substantiate, if possible, the promising evidence that has been found in case series.
药物、心理治疗和其他治疗方式对许多精神疾病患者有效。尽管如此,许多患者在现有的干预措施下并未完全缓解,且复发率很高。在寻找难治性疾病的进一步治疗方法的过程中,人们对包括侵入性在内的焦点神经调节技术,尤其是深部脑刺激(DBS),重新产生了兴趣。
在这篇综述文章中,由神经外科医生、精神科医生和一名执业伦理学家/神经学家组成的小组总结了 DBS 治疗精神疾病的主要方面,并就其适应症和实际实施提出了建议。
迄今为止发表的随机对照试验(RCT)并未证实 DBS 对精神疾病的疗效。这可能是因为随访时间太短。与阴性 RCT 相反,病例系列确实表明 DBS 对严重抑郁症有积极作用,但这种作用只能在手术后几个月才能看到。
DBS 可能是其他治疗方法无效的严重精神疾病患者的一种治疗选择。只有在临床试验的环境下才能对患者进行治疗。必须进行随访时间更长的 RCT,以证实病例系列中发现的有希望的证据,如果可能的话。